CD56bright natural killer (NK) cells: An important NK cell subset

Immunology

Volumn 126, Issue 4, 2009, Pages 458-465

  Poli, Aurélie ^a   Michel, Tatiana ^a   Thérésine, Maud ^a   Andrès, Emmanuel ^b   Hentges, François ^a   Zimmer, Jacques ^a  

^a LUXEMBOURG INSTITUTE OF HEALTH   (Luxembourg)

^b UNIVERSITY HOSPITAL OF STRASBOURG   (France)

Author keywords

CD56bright; Immunoregulation; Natural killer cells

Indexed keywords

BETA INTERFERON; CD56 ANTIGEN; CYTOKINE; DACLIZUMAB;

BLOOD; CELL EXPANSION; CELL FUNCTION; CELL INTERACTION; CLINICAL TRIAL; GENERAL ASPECTS OF DISEASE; HUMAN; IMMUNE SYSTEM; IMMUNOREGULATION; LYMPHOID TISSUE; MULTIPLE SCLEROSIS; NATURAL KILLER CELL; PATHOLOGY; PHENOTYPE; PRIORITY JOURNAL; REVIEW; UTERUS; CYTOTOXICITY; FEMALE; IMMUNOLOGY; IMMUNOPHENOTYPING; LYMPHOCYTE SUBPOPULATION;

ANTIGENS, CD56; CYTOTOXICITY, IMMUNOLOGIC; FEMALE; HUMANS; IMMUNOPHENOTYPING; KILLER CELLS, NATURAL; LYMPHOCYTE SUBSETS; LYMPHOID TISSUE; UTERUS;

EID: 61449115971     PISSN: 00192805     EISSN: 13652567     Source Type: Journal    
DOI: 10.1111/j.1365-2567.2008.03027.x     Document Type: Review

References (53)

1. Cooper MA, Fehniger TA, Caligiuri MA. The biology of human natural killer-cell subsets. Trends Immunol 2001 22 : 633 40.
2. + natural killer (NK) cells: a highly dysfunctional NK subset expanded in HIV-infected viremic individuals. Proc Natl Acad Sci USA 2005 102 : 2886 91.
3. Caligiuri M. Human natural killer cells. Blood 2008 112 : 461 9.
4. Hayakawa Y, Huntington ND, Nutt SL, Smyth MJ. Functional subsets of mouse natural killer cells. Immunol Rev 2006 214 : 47 55.
5. Wilk E, Kalippke K, Buyny S, Schmidt RE, Jacobs R. New aspects of NK cell subset identification and inference of NK cells' regulatory capacity by assessing functional and genomic profiles. Immunobiology 2008 213 : 271 83.
6. Nagler A, Lanier LL, Cwirla S, Phillips JH. Comparative studies of human FcRIII-positive and negative natural killer cells. J Immunol 1989 143 : 3183 91.
7. dim NK cells. Eur J Immunol 2001 31 : 3121 6.
8. Lanier LL. NK cell receptors. Annu Rev Immunol 1998 16 : 359 93.
9. Vitale M, Zimmer J, Castriconi R et al. Analysis of natural killer cells in TAP2-deficient patients: expression of functional triggering receptors and evidence for the existence of inhibitory receptor(s) that prevent lysis of normal autologous cells. Blood 2002 99 : 1723 9.
10. Wendt K, Wilk E, Buyny S, Schmidt RE, Jacobs R. Interleukin-21 differentially affects human natural killer cell subsets. Immunology 2007 122 : 486 95.
11. + NK and NK-T peripheral blood lymphocytes identified by chemokine receptor expression repertoire. J Immunol 2001 166 : 6477 82.
12. bright+ natural killer cell subpopulations. Int Arch Allergy Immunol 1996 110 : 308 13.
13. Anumanthan A, Bensussan A, Boumsell L et al. Cloning of BY55, a novel Ig superfamily member expressed on NK cells, CTL, and intestinal intraepithelial lymphocytes. J Immunol 1998 161 : 2780 90.
14. - lymphocytes (NK cells). Cell Immunol 1995 165 : 294 301.
15. Hanna J, Bechtel P, Zhai Y, Youssef F, McLachlan K, Mandelboim O. Novel insights on human NK cells' immunological modalities revealed by gene expression profiling. J Immunol 2004 173 : 6547 63.
16. bright NK cells. J Leukoc Biol 2006 80 : 1529 41.
17. Fehniger TA, Shah MH, Turner MJ et al. Differential cytokine and chemokine gene expression by human NK cells following activation with IL-18 or IL-15 in combination with IL-12: implications for the innate immune response. J Immunol 1999 162 : 4511 20.
18. Ferlazzo G, Thomas D, Lin SL, Goodman K, Morandi B, Muller WA, Moretta A, Münz C. The abundant NK cells in human secondary lymphoid tissues require activation to express killer cell Ig-like receptors and become cytolytic. J Immunol 2004 172 : 1455 62.
19. bright natural killer cells are present in human lymph nodes and are activated by T cell-derived IL-2: a potential new link between adaptive and innate immunity. Blood 2003 101 : 3052 7.
20. Ferlazzo G, Münz C. NK cell compartments and their activation by dendritic cells. J Immunol 2004 172 : 1333 9.
21. Vitale M, Bottino C, Sivori S et al. NKp44, a novel triggering surface molecule specifically expressed by activated natural killer cells, is involved in non-major histocompatibility complex-restricted tumor cell lysis. J Exp Med 1998 187 : 2065 72.
22. Saito S, Nakashima A, Myojo-Higuma S, Shiozaki A. The balance between cytotoxic NK cells and regulatory NK cells in human pregnancy. J Reprod Immunol 2008 77 : 14 22.
23. Koopman LA, Kopcow HD, Rybalov B et al. Human decidual natural killer cells are a unique NK subset with immunomodulatory potential. J Exp Med 2003 198 : 1201 12.
24. - natural killer cells is selectively responsible for both proliferation and interferon-γ production upon interaction with dendritic cells. Eur J Immunol 2004 34 : 1715 22.
25. bright NK cells are enriched at inflammatory sites and can engage with monocytes in a reciprocal program of activation. J Immunol 2004 173 : 6418 26.
26. André P, Spertini O, Guia S et al. Modification of P-selectin glycoprotein ligand-1 with a natural killer cell-restricted sulphated lactosamine creates an alternate ligand for L-selectin. Proc Natl Acad Sci U S A 2000 97 : 3400 5.
27. dim cells: role of contact with peripheral fibroblasts. J Immunol 2007 179 : 89 94.
28. dim NK cells upon activation. J Immunol 2008 178 : 4947 55.
29. Ouyang Q, Baerlocher G, Vulto I, Lansdorp PM. Telomere length in human natural killer cell subsets. Ann N Y Acad Sci 2007 1106 : 240 52.
30. - NK cells with similarities to decidual NK cells. Proc Natl Acad Sci USA 2007 104 : 3378 83.
31. Carson W, Caligiuri M. Natural killer cell subsets and development. Methods 1996 9 : 327 43.
32. Zimmer J, Bausinger H, Andrès E, Donato L, Hanau D, Hentges F, Moretta A, de la Salle H. Phenotypic studies of natural killer cell subsets in human transporter associated with antigen processing deficiency. PLoS ONE 2007 2 : e1033.
33. Villa-Forte A, de la Salle H, Fricker D, Hentges F, Zimmer J. HLA class I deficiency syndrome mimicking Wegener's granulomatosis. Arthritis Rheum 2008 58 : 2579 82.
34. Cac NC, Ballas ZK. Recalcitrant warts, associated with natural killer cell dysfunction, treated with systemic IFN-α. J Allergy Clin Immunol 2006 118 : 526 8.
35. bright natural killer cells in the peripheral blood of multiple sclerosis patients treated with interferon-beta. Neurol Sci 2007 28 : 121 6.
36. bright natural killer cells mediate immunomodulatory effects of IL-2Rα -targeted therapy (daclizumab) in multiple sclerosis. Proc Natl Acad Sci U S A 2006 103 : 5941 6.
37. bright regulatory NK cells in patients with active uveitis. J Immunol 2005 174 : 5187 91.
38. Vivier E, Tomasello E, Baratin M, Walzer T, Ugolini S. Functions of natural killer cells. Nat Immunol 2008 9 : 503 10.
39. bright NK cells. Scand J Infect Dis 2006 38 : 1122 5.
40. - natural killer cells in a case of X-SCID with Omenn syndrome-like manifestations. Eur J Haematol 2007 79 : 81 85.
41. Golden-Mason L, Madrigal-Estebas L, McGrath E, Conroy MJ, Ryan EJ, Hegarty JE, O'Farrelly C, Doherty DG. Altered natural killer cell subset distributions in resolved and persistent hepatitis C virus infection following single source exposure. Gut 2008 57 : 1121 8.
42. Barcelos W, Sathler-Avelar R, Martins-Filho OA et al. Natural killer cell subpopulations in putative resistant individuals and patients with active Mycobacterium tuberculosis infection. Scand J Immunol 2008 68 : 92 102.
43. bright natural killer cells in active and inactive systemic lupus erythematosus. Immunology 2009 126 : 140 6.
44. Gumá M, Angulo A, Vilches C, Gómez-Lozano N, Malats N, López-Botet M. Imprint of human cytomegalovirus infection on the NK cell receptor repertoire. Blood 2004 104 : 3664 71.
45. Gumá M, Cabrera C, Erkizia I, Bofill M, Clotet B, Ruiz L, López-Botet M. Human cytomegalovirus infection is associated with increased proportions of NK cells that express the CD94/NKG2C receptor in aviremic HIV-1-positive patients. J Infect Dis 2006 194 : 38 41.
46. Mela CM, Burton CT, Imami N, Nelson M, Steel A, Gazzard BG, Gotch FM, Goodier MR. Switch from inhibitory to activating NKG2 receptor expression in HIV-1 infection: lack of reversion with highly active antiretroviral therapy. AIDS 2005 19 : 1761 9.
47. dim natural killer cells. J Reprod Immunol 2006 70 : 33 42.
48. - NK cells accumulate in psoriatic skin in response to CXCL10 and CCL5 and exacerbate skin inflammation. Eur J Immunol 2006 36 : 118 28.
49. negative phenotype. Rheumatology 2003 42 : 870 8.
50. + T-cells in sarcoidosis patients. Eur Respir J 2005 26 : 77 85.
51. Hak L, Mysliwska J, Wieckiewicz J, Szyndler K, Trzonkowski P, Siebert J, Mysliwski A. NK cell compartment in patients with coronary heart disease. Immun Ageing 2007 4 : 3.
52. Scordamaglia F, Balsamo M, Scordamaglia A, Moretta A, Mingari MC, Canonica GW, Moretta L, Vitale M. Perturbations of natural killer cell regulatory functions in respiratory allergic diseases. J Allergy Clin Immunol 2008 121 : 479 85.
53. Villanueva J, Lee S, Giannini EH, Graham TB, Passo MH, Filipovich A, Grom AA. Natural killer cell dysfunction is a distinguishing feature of systemic onset juvenile rheumatoid arthritis and macrophage activation syndrome. Arthritis Res Ther 2005 7 : R30 7.